目的评价棓丙酯对急性脑梗死患者的临床疗效和安全性。方法将120例急性脑梗死患者随机分为两组,治疗组在常规治疗的基础上加用棓丙酯,对照组只按常规治疗。观察两组治疗前后神经功能缺损积分及血液动力学的变化。结果治疗组临床基本治愈率为30%,显著进步率为45%,显效率为75%,有效率95%,与对照组比较差异显著(P<0.05)。无出血并发症。结论棓丙酯治疗急性脑梗死安全有效。 Objective To evaluate the clinical efficacy and safety of propyl gallate in patients with acute cerebral infarction. Methods A total of 120 patients with acute cerebral infarction were randomly divided into two groups. The treatment group was given propyl gallate on the basis of routine treatment, while the control group was treated only routinely. The changes of neurological deficit score and hemodynamics before and after treatment were observed. Results The basic cure rate was 30%, the significant improvement rate was 45%, the effective rate was 75% and the effective rate was 95%. The difference was significant (P <0.05) compared with the control group. No bleeding complications. Conclusion Cerebellar propyl ester is safe and effective in the treatment of acute cerebral infarction.